Fig. 4.
Fig. 4. Cumulative incidence of EBV reactivation more than or equal to 1000 geq/mL. / Cumulative incidence of EBV reactivation more than or equal to 1000 geq/mL in prospectively studied EBV-seropositive donor/recipient pairs (n = 48) versus the incidence in the historical control group (n = 85) (P = .86).

Cumulative incidence of EBV reactivation more than or equal to 1000 geq/mL.

Cumulative incidence of EBV reactivation more than or equal to 1000 geq/mL in prospectively studied EBV-seropositive donor/recipient pairs (n = 48) versus the incidence in the historical control group (n = 85) (P = .86).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal